Transfusion-related risk of secondary bacterial infections in sepsis patients: A retrospective cohort study

Shock

Volumn 35, Issue 4, 2011, Pages 355-359

  Juffermans, Nicole P ^a   Prins, David J ^a   Vlaar, Alexander P J ^a   Nieuwland, Rienk ^a   Binnekade, Jan M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Critically ill; Immunomodulation; Nosocomial infection; Platelets; Red blood cells; Sepsis

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; BACTERIAL INFECTION; BLOOD STORAGE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY INFECTION; SEPSIS; THROMBOCYTE TRANSFUSION; AGED; BLOOD TRANSFUSION; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; BACTERIAL INFECTIONS; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; SEPSIS;

EID: 79958005154     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182086094     Document Type: Article

References (31)

1. Brun-Buisson C, Meshaka P, Pinton P, Vallet B: EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30(4):580-588, 2004.
2. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35(5):1244-1250, 2007.
3. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14(1-2):64-78, 2008.
4. Mincheff MS, Meryman HT, Kapoor V, Alsop P, Wotzel M: Blood transfusion and immunomodulation: a possible mechanism. Vox Sang 65(1):18-24, 1993.
5. Ghio M, Contini P, Mazzei C, Brenci S, Filaci G, Indiveri F, Puppo F: Soluble HLA class I and Fas ligand molecules in blood components and their role in the immunomodulatory effects of blood transfusions. Leuk Lymphoma 39(1-2):29-36, 2000.
6. Nielsen HJ, Reimert CM, Pedersen AN, Brunner N, Edvardsen L, Dybkjaer E, Kehlet H, Skov PS: Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 36(11-12):960-965, 1996.
7. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH: Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358(12):1229-1239, 2008.
8. Mynster T, Nielsen HJ: The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol 35(2):212-217, 2000.
9. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC: Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 137(6):711-716, 2002.
10. Purdy FR, Tweeddale MG, Merrick PM: Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth 44(12):1256-1261, 1997.
11. Aslam R, Speck ER, Kim M, Freedman J, Semple JW: Transfusionrelated immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells. Transfusion 48(9): 1778-1786, 2008.
12. Geiger TL: Transfusion-associated immune modulation: a reason to TRIM platelet transfusions? Transfusion 48(9):1772-1773, 2008.
13. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A: Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44(8):1143-1148, 2004.
14. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Meineri M, Wasowicz M, McCluskey SA, Beattie WS: Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth 53(3): 279-287, 2006.
15. Vamvakas EC: Platelet transfusion and postoperative infection in cardiac surgery. Transfusion 47(2):352-354, 2007.
16. Marik PE, Corwin HL: Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 36(9):2667-2674, 2008.
17. Arts D, de KN, Scheffer GJ, de JE: Quality of data collected for severity of illness scores in the Dutch National Intensive Care Evaluation (NICE) registry. Intensive Care Med 28(5):656-659, 2002.
18. Arts DG, De Keizer NF, Scheffer GJ: Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc 9(6):600-611, 2002.
19. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, et al.: International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323-2329, 2009.
20. Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, Barz D, Reinhart K: Anemia and blood transfusion in a surgical intensive care unit. Crit Care 14(3):R92, 2010.
21. Vamvakas EC, Blajchman MA: Transfusion-related immunomodulation (TRIM): an update. Blood Rev 21(6):327-348, 2007.
22. Weinberg JA, McGwin G Jr, Marques MB, Cherry SA III, Reiff DA, Kerby JD, Rue LW III: Transfusions in the less severely injured: does age of transfused blood affect outcomes? J Trauma 65(4):794-798, 2008.
23. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS: Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 68(7):566-572, 2002.
24. Keller ME, Jean R, LaMorte WW, Millham F, Hirsch E: Effects of age of transfused blood on length of stay in trauma patients: a preliminary report. J Trauma 53(5):1023-1025, 2002.
25. Weinberg JA, McGwin G Jr, Griffin RL, Huynh VQ, Cherry SA III, Marques MB, Reiff DA, Kerby JD, Rue LW III: Age of transfused blood: an independent predictor of mortality despite universal leukoreduction. J Trauma 65(2):279-282, 2008.
26. McGrath T, Koch CG, Xu M, Li L, Mihaljevic T, Figueroa P, Blackstone EH: Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes. Ann Thorac Surg 86(2):543-553, 2008.
27. Pitchford SC, Momi S, Giannini S, Casali L, Spina D, Page CP, Gresele P: Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood 105(5): 2074-2081, 2005.
28. Asaduzzaman M, Rahman M, Jeppsson B, Thorlacius H: P-selectin glycoproteinligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis. Br J Pharmacol 156(2):307-315, 2009.
29. Rahman M, Zhang S, Chew M, Ersson A, Jeppsson B, Thorlacius H: Plateletderived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury. Ann Surg 250(5):783-790, 2009.
30. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC: Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 108(7):2455-2462, 2006.
31. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, Kesecioglu J: Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362(9389):1011-1016, 2003.